Dr. C. Tuna Acne Pore Purifying Toner

Description

The drug is identified by the SPL code 34089-3. It is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as lactose monohydrate, microcrystalline cellulose, sodium starch glycolate, and magnesium stearate.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

After cleansing the skin, the product should be applied to the face using a soft cotton ball or pad. Care should be taken to avoid the eye area during application. The product should not be rinsed off after application. Following the application, it is recommended to use the Acne Blemish Control Serum to enhance treatment efficacy.

Contraindications

Use is contraindicated in individuals with very sensitive skin or those who have a known sensitivity to salicylic acid. Due to the potential for adverse reactions, these conditions may exacerbate skin irritation or other side effects associated with the product.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients that skin irritation and dryness may be exacerbated when this product is used in conjunction with other topical acne treatments. To minimize the risk of irritation, it is recommended that patients use only one topical acne product at a time.

Patients should be cautioned to avoid sun exposure while using this product and to apply a broad-spectrum sunscreen to protect the skin. Additionally, contact with the eyes, lips, and mouth should be strictly avoided. In the event of accidental contact, patients should flush the affected area thoroughly with water. Signs of skin irritation, such as redness or tingling, may occur; should these symptoms intensify, patients are advised to discontinue use and seek medical advice.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

This product is contraindicated for individuals with very sensitive skin or those who have a known sensitivity to salicylic acid.

Side Effects

Patients using this product should be aware that it is for external use only. Skin irritation and dryness are common adverse reactions, particularly when this product is combined with other topical acne skincare products. Symptoms of skin irritation may include redness or tingling; if these symptoms intensify, patients are advised to discontinue use and seek medical advice.

It is important for patients to avoid sun exposure while using this product and to apply a sunscreen to mitigate potential adverse effects. Additionally, contact with the eyes, lips, and mouth should be avoided; in the event of contact, the affected area should be flushed thoroughly with water.

Patients with very sensitive skin or those who are sensitive to salicylic acid should not use this product. In the case of accidental ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Drug Interactions

The concomitant use of this product with other topical acne skincare products may increase the likelihood of skin irritation and dryness. To mitigate the risk of adverse effects, it is advised that only one topical acne skincare product be utilized at a time. If irritation occurs, discontinuation of the additional product is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when using multiple topical agents.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. C. Tuna Acne Pore Purifying Toner (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Dr. C. Tuna Acne Pore Purifying Toner in geriatric patients. The drug insert does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when recommending this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment outcomes in this population.

Pregnancy

There is no specific information regarding the use of Dr. C. Tuna Acne Pore Purifying Toner in pregnant patients. Due to the absence of data, healthcare professionals are advised to exercise caution when recommending this product to women of childbearing potential. The potential effects on fetal outcomes remain unknown, and the safety of this product during pregnancy has not been established. It is recommended that pregnant patients consult their healthcare provider before using this toner to ensure appropriate guidance and consideration of individual circumstances.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants during the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this drug. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management procedures.

Healthcare providers should ensure that patients are monitored closely for any signs of toxicity and that supportive care is initiated as necessary.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients that they should not use this product if they have very sensitive skin or a known sensitivity to salicylic acid.

Healthcare providers should discuss the potential for skin irritation and dryness, particularly if the patient is using other topical acne skincare products. Patients should be instructed to use only one topical acne product at a time to minimize the risk of irritation.

Patients should be cautioned to avoid sun exposure while using this product and to apply a broad-spectrum sunscreen to protect their skin. Additionally, they should be informed to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, patients should flush the area thoroughly with water.

It is essential to communicate that skin irritation may occur, which can be characterized by redness or tingling. If patients experience increased irritation, they should discontinue use and seek medical advice promptly.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically. Clinicians should counsel patients to avoid sun exposure and to use sunscreen during treatment. Patients are advised to avoid contact with the eyes, lips, and mouth; in the event of contact, they should flush the area thoroughly with water. Skin irritation, such as redness or tingling, may occur; if these symptoms worsen, patients should discontinue use and seek medical advice.

Drug Information (PDF)

This file contains official product information for Dr. C. Tuna Acne Pore Purifying Toner, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)